asa glp 1 guidelines 2025 Advises No Longer Holding GLP-1 Agents Prior to Surgery for Most Patients Anesthetic Considerations for Patients Taking

Several macro and micro-level drivers are driving this obesity care revolution: Rising Prevalence : By 2030, nearly half the worlds population will be living with overweight or obesity, an alarming epidemiological trend that brings public health systems to a tipping point

What's New with GLP-1 Coverage in 2026 While GLP-1 agonists have been around for over a decade now, they've seen a big jump in popularity in the last couple of years

Does methylene blue affect the total amount of glucose that has been metabolised

SGLT2 inhibitors, for instance, may increase the risk of genital yeast infections

showed "GSH was highly tolerated and its administration was not associated with any signs of adverse effects." [2] Blood chemistry markers, including liver and kidney function tests, remain unaffected even with extended use